ShareThis Page
Business Briefs

Monsanto appeals $78M verdict in California weed killer suit

| Tuesday, Nov. 20, 2018, 8:27 p.m.

SAN FRANCISCO — Agribusiness giant Monsanto is appealing a $78 million verdict in favor of a dying California man who said the company’s widely used Roundup weed killer was a major factor in his cancer.

The company filed a notice of appeal Tuesday in San Francisco Superior Court challenging the August jury verdict in favor of DeWayne Johnson.

Bayer, which acquired Monsanto in June, said in a statement that none of the science presented at trial supports the conclusion that Roundup was a substantial cause of Johnson’s non-Hodgkin’s lymphoma.

An email to a spokeswoman for Johnson’s attorneys was not immediately returned.

Bayer says numerous studies have shown glyphosate, the active ingredient in the weed killer, is safe when used properly.

TribLIVE commenting policy

You are solely responsible for your comments and by using TribLive.com you agree to our Terms of Service.

We moderate comments. Our goal is to provide substantive commentary for a general readership. By screening submissions, we provide a space where readers can share intelligent and informed commentary that enhances the quality of our news and information.

While most comments will be posted if they are on-topic and not abusive, moderating decisions are subjective. We will make them as carefully and consistently as we can. Because of the volume of reader comments, we cannot review individual moderation decisions with readers.

We value thoughtful comments representing a range of views that make their point quickly and politely. We make an effort to protect discussions from repeated comments either by the same reader or different readers

We follow the same standards for taste as the daily newspaper. A few things we won't tolerate: personal attacks, obscenity, vulgarity, profanity (including expletives and letters followed by dashes), commercial promotion, impersonations, incoherence, proselytizing and SHOUTING. Don't include URLs to Web sites.

We do not edit comments. They are either approved or deleted. We reserve the right to edit a comment that is quoted or excerpted in an article. In this case, we may fix spelling and punctuation.

We welcome strong opinions and criticism of our work, but we don't want comments to become bogged down with discussions of our policies and we will moderate accordingly.

We appreciate it when readers and people quoted in articles or blog posts point out errors of fact or emphasis and will investigate all assertions. But these suggestions should be sent via e-mail. To avoid distracting other readers, we won't publish comments that suggest a correction. Instead, corrections will be made in a blog post or in an article.

click me